Target intelligence / Profile preview

G protein subunit gamma 11 (GNG11)

Target
GNG11
Molecular classification
G protein gamma subunit, Heterotrimeric G protein component, Lipid-anchored cell membrane protein[1][4][8]
01

Overview

G protein subunit gamma 11 is a member of the gamma subunit family of heterotrimeric guanine nucleotide-binding proteins (G proteins) and is encoded by the GNG11 gene in humans. As part of the heterotrimeric G protein complex (which also includes alpha and beta subunits), GNG11 is anchored to the cell membrane via lipid modification and is essential for the complex’s function in coupling G protein-coupled receptors (GPCRs) to downstream signaling pathways. This protein is required for correct signal transduction processes—including the regulation of second messenger pathways—and enables G protein beta-subunit binding. Altered expression of GNG11 has been found in certain disease states, including lymphomas and retinal degenerative diseases, although there are currently no drugs known to specifically target this subunit or clinical mechanisms of action established for pharmacologic intervention[1][4][8].

Other names
G protein subunit gamma 11G protein gamma-11 subunitGNG11GNGT11G protein gamma 11 subunitguanine nucleotide-binding protein G(I)/G(S)/G(O) gamma-11 subunitG protein subunit γ 11guanine nucleotide binding protein (G protein), gamma 11HG3H1guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11heterotrimeric guanine nucleotide-binding protein 3H1[1][4]
02

Biological functions

Signal transduction (via G protein-coupled receptor [GPCR] pathways)G protein beta-subunit bindingModulation of transmembrane signalingRegulator of effector proteinsGolgi vesiculation and intracellular trafficking[3][4][8]
03

Disease associations

Cancer (e.g., downregulation in splenic marginal zone lymphoma, involvement in various cancers)Cone-rod dystrophy 10[4][8]
04

Biomarkers

Downregulation may serve as a potential marker in splenic marginal zone lymphoma[4]

Beyond the preview

Go deeper on G protein subunit gamma 11 (GNG11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G protein subunit gamma 11 (GNG11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call